» Articles » PMID: 36145871

Electrospun Nanofiber Composites for Drug Delivery: A Review on Current Progresses

Abstract

A medication's approximate release profile should be sustained in order to generate the desired therapeutic effect. The drug's release site, duration, and rate must all be adjusted to the drug's therapeutic aim. However, when designing drug delivery systems, this may be a considerable hurdle. Electrospinning is a promising method of creating a nanofibrous membrane since it enables drugs to be placed in the nanofiber composite and released over time. Nanofiber composites designed through electrospinning for drug release purposes are commonly constructed of simple structures. This nanofiber composite produces matrices with nanoscale fiber structure, large surface area to volume ratio, and a high porosity with small pore size. The nanofiber composite's large surface area to volume ratio can aid with cell binding and multiplication, drug loading, and mass transfer processes. The nanofiber composite acts as a container for drugs that can be customized to a wide range of drug release kinetics. Drugs may be electrospun after being dissolved or dispersed in the polymer solution, or they can be physically or chemically bound to the nanofiber surface. The composition and internal structure of the nanofibers are crucial for medicine release patterns.

Citing Articles

Methyl Gallate and Amoxicillin-Loaded Electrospun Poly(vinyl alcohol)/Chitosan Mats: Impact of Acetic Acid on Their Anti- Activity.

Jiamboonsri P, Sangkhun W, Wanwong S Polymers (Basel). 2025; 17(1.

PMID: 39795411 PMC: 11723412. DOI: 10.3390/polym17010007.


Synergistic Effects of Radical Distributions of Soluble and Insoluble Polymers within Electrospun Nanofibers for an Extending Release of Ferulic Acid.

Dong R, Gong W, Guo Q, Liu H, Yu D Polymers (Basel). 2024; 16(18).

PMID: 39339078 PMC: 11435815. DOI: 10.3390/polym16182614.


The mechanism of low molecular weight fucoidan-incorporated nanofiber scaffolds inhibiting oral leukoplakia via SR-A/Wnt signal axis.

Xu M, Sun Y, Cong B, Zhang X, Li Z, Liu Y Front Pharmacol. 2024; 15:1397761.

PMID: 39104391 PMC: 11298705. DOI: 10.3389/fphar.2024.1397761.


Controlled Delivery of Rosuvastatin or Rapamycin through Electrospun Bismuth Nanoparticle-Infused Perivascular Wraps Promotes Arteriovenous Fistula Maturation.

Barcena A, Perez J, Bernardino M, San Valentin E, Damasco J, Klusman C ACS Appl Mater Interfaces. 2024; 16(26):33159-33168.

PMID: 38912610 PMC: 11725229. DOI: 10.1021/acsami.4c06042.


Cracking the Code: Enhancing Molecular Tools for Progress in Nanobiotechnology.

Avila Y, Rebolledo L, Skelly E, de Freitas Saito R, Wei H, Lilley D ACS Appl Bio Mater. 2024; 7(6):3587-3604.

PMID: 38833534 PMC: 11190997. DOI: 10.1021/acsabm.4c00432.


References
1.
Mombini S, Mohammadnejad J, Bakhshandeh B, Narmani A, Nourmohammadi J, Vahdat S . Chitosan-PVA-CNT nanofibers as electrically conductive scaffolds for cardiovascular tissue engineering. Int J Biol Macromol. 2019; 140:278-287. DOI: 10.1016/j.ijbiomac.2019.08.046. View

2.
Xue J, Xie J, Liu W, Xia Y . Electrospun Nanofibers: New Concepts, Materials, and Applications. Acc Chem Res. 2017; 50(8):1976-1987. PMC: 6589094. DOI: 10.1021/acs.accounts.7b00218. View

3.
Nune M, Manchineella S, T G, K S N . Melanin incorporated electroactive and antioxidant silk fibroin nanofibrous scaffolds for nerve tissue engineering. Mater Sci Eng C Mater Biol Appl. 2018; 94:17-25. DOI: 10.1016/j.msec.2018.09.014. View

4.
Xu H, Zhang F, Wang M, Lv H, Yu D, Liu X . Electrospun hierarchical structural films for effective wound healing. Biomater Adv. 2022; 136:212795. DOI: 10.1016/j.bioadv.2022.212795. View

5.
Guo S, Jiang W, Shen L, Zhang G, Gao Y, Yang Y . Electrospun Hybrid Films for Fast and Convenient Delivery of Active Herb Extracts. Membranes (Basel). 2022; 12(4). PMC: 9031211. DOI: 10.3390/membranes12040398. View